Exosomes from retinal astrocytes contain antiangiogenic components that inhibit laser-induced choroidal neovascularization

Journal of Biological Chemistry

Volumn 288, Issue 39, 2013, Pages 28058-28067

  Hajrasouliha, Amir Reza ^a   Jiang, Guomin ^a   Lu, Qingxian ^a   Lu, Huayi ^a   Kaplan, Henry J ^a   Zhang, Huang Ge ^b   Shao, Hui ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ANTIANGIOGENIC; CHOROIDAL NEOVASCULARIZATION; CLINICAL APPLICATION; LASER INDUCED; MONOLAYER CULTURE; RETINAL CELLS; RETINAL PIGMENT EPITHELIUM;

BIOCHEMISTRY; BIOLOGY;

OPHTHALMOLOGY;

COLLAGEN TYPE 18; ENDOSTATIN; MATRIX METALLOPROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ISOLATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; DENDRITIC CELL; ENDOTHELIUM CELL; EXOSOME; EYE PROTECTION; FEMALE; FLUORESCENCE MICROSCOPY; INTERNALIZATION; LASER; NONHUMAN; PERITONEUM MACROPHAGE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RETINA; RETINAL ASTROGLIAL CELL; RETINAL MICROVASCULAR ENDOTHELIAL CELL; SUBRETINAL NEOVASCULARIZATION;

AGE-RELATED MACULAR DEGENERATION; ANGIOGENESIS; CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL CELL; EXOSOMES; INFLAMMATION; MACROPHAGES; RETINAL ASTROCYTES; RETINAL PIGMENTAL EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ANGIOGENESIS INHIBITORS; ANIMALS; ASTROCYTES; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; CHOROIDAL NEOVASCULARIZATION; EXOSOMES; FEMALE; INFLAMMATION; LASERS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; RETINA; RETINAL PIGMENT EPITHELIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884766718     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.470765     Document Type: Article

References (44)

1. Théry, C., Zitvogel, L., and Amigorena, S. (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579
2. Zhang, H. G., and Grizzle, W. E. (2011) Exosomes and cancer: a newly described pathway of immune suppression. Clin. Cancer Res. 17, 959-964
3. Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J. D., and Song, E. (2011) Microvesicles secreted by macrophages shuttle invasionpotentiating microRNAs into breast cancer cells. Mol. Cancer 10, 117
4. Martinez, M. C., and Andriantsitohaina, R. (2011) Microparticles in angiogenesis: therapeutic potential. Circ. Res. 109, 110-119
5. Bussolati, B., Grange, C., and Camussi, G. (2011) Tumor exploits alternative strategies to achieve vascularization. FASEB J. 25, 2874-2882
6. Park, J. E., Tan, H. S., Datta, A., Lai, R. C., Zhang, H., Meng, W., Lim, S. K., and Sze, S. K. (2010) Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 9, 1085-1099
7. Martínez, M. C., Larbret, F., Zobairi, F., Coulombe, J., Debili, N., Vainchenker, W., Ruat, M., and Freyssinet, J. M. (2006) Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood 108, 3012-3020
8. Couch, S. M., and Bakri, S. J. (2011) Review of combination therapies for neovascular age-related macular degeneration. Semin. Ophthalmol. 26, 114-120
9. Witmer, A. N., Vrensen, G. F.., Van Noorden, C. J., and Schlingemann, R. O. (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22, 1-29
10. Takeda, A., Baffi, J. Z., Kleinman, M. E., Cho, W. G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R. J., Dridi, S., Saito, K., Raisler, B. J., Budd, S. J., Geisen, P., Munitz, A., Ambati, B. K., Green, M. G., Ishibashi, T., Wright, J. D., Humbles, A. A., Gerard, C. J., Ogura, Y., Pan, Y., Smith, J. R., Grisanti, S., Hartnett, M. E., Rothenberg, M. E., and Ambati, J. (2009) CCR3 is a therapeutic and diagnostic target for neovascular age-related macular degeneration. Nature 460, 225-230
11. Mullins, R. F., Aptsiauri, N., and Hageman, G. S. (2001) Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye 15, 390-395
12. Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., and Anderson, D. H. (2002) The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 99, 11830-11835
13. Penfold, P. L., Madigan, M. C., Gillies, M. C., and Provis, J. M. (2001) Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res. 20, 385-414
14. Lavalette, S., Raoul, W., Houssier, M., Camelo, S., Levy, O., Calippe, B., Jonet, L., Behar-Cohen, F., Chemtob, S., Guillonneau, X., Combadière, C., and Sennlaub, F. (2011) Interleukin-1 inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am. J. Pathol. 178, 2416-2423
15. Chan, C. C., Ross, R. J., Shen, D., Ding, X., Majumdar, Z., Bojanowski, C. M., Zhou, M., Salem, N., Jr., Bonner, R., and Tuo, J. (2008) Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 40, 124-128
16. Fujimoto, T., Sonoda, K. H., Hijioka, K., Sato, K., Takeda, A., Hasegawa, E., Oshima, Y., and Ishibashi, T. (2010) Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 51, 4694-4702
17. Cho, Y., Wang, J. J., Chew, E. Y., Ferris, F. L., 3rd, Mitchell, P., Chan, C. C., and Tuo, J. (2009) Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples. Invest. Ophthalmol. Vis. Sci. 50, 5614-5618
18. Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P., Charbel Issa, P., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., Superti-Furga, G., Handa, J. T., Zipfel, P. F., Witztum, J. L., and Binder, C. J. (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478, 76-81
19. Totan, Y., Yaǧci, R., Bardak, Y., Ozyurt, H., Kendir, F., Yilmaz, G., Sahin, S., and Sahin Tiǧ, U. (2009) Oxidative macromolecular damage in age-related macular degeneration. Curr. Eye Res. 34, 1089-1093
20. Ethen, C. M., Reilly, C., Feng, X., Olsen, T. W., and Ferrington, D. A. (2007) Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest. Ophthalmol. Vis. Sci. 48, 3469-3479
21. Jiang, G., Ke, Y., Sun, D., Han, G., Kaplan, H. J., and Shao, H. (2008) Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Invest. Ophthalmol. Vis. Sci. 49, 282-289
22. Jiang, G., Sun, D., Kaplan, H. J., and Shao, H. (2012) Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells. PLoS ONE 7, e40510
23. Jiang, G., Ke, Y., Sun, D., Wang, Y., Kaplan, H. J., and Shao, H. (2009) Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest. Ophthalmol. Vis. Sci. 50, 4769-4776
24. Liu, Y., Clem, B., Zuba-Surma, E. K., El-Naggar, S., Telang, S., Jenson, A. B., Wang, Y., Shao, H., Ratajczak, M. Z., Chesney, J., and Dean, D. C. (2009) Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype. Cell Stem Cell 4, 336-347
25. Liu, C., Yu, S., Zinn, K., Wang, J., Zhang, L., Jia, Y., Kappes, J. C., Barnes, S., Kimberly, R. P., Grizzle, W. E., and Zhang, H. G. (2006) Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J. Immunol. 176, 1375-1385
26. Bora, P. S., Hu, Z., Tezel, T. H., Sohn, J. H., Kang, S. G., Cruz, J. M., Bora, N. S., Garen, A., and Kaplan, H. J. (2003) Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc. Natl. Acad. Sci. U.S.A. 100, 2679-2684
27. Ray, A., and Dittel, B. N. (2010) Isolation of mouse peritoneal cavity cells. J. Vis. Exp. 28, 1488
28. Liao, T., Ke, Y., Shao, W. H., Haribabu, B., Kaplan, H. J., Sun, D., and Shao, H. (2006) Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 47, 1543-1549
29. Patel, M., and Chan, C. C. (2008) Immunopathological aspects of agerelated macular degeneration. Semin. Immunopathol. 30, 97-110
30. Cao, X., Shen, D., Patel, M. M., Tuo, J., Johnson, T. M., Olsen, T. W., and Chan, C. C. (2011) Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol. Int. 61, 528-535
31. Wang, Y., Wang, V. M., and Chan, C. C. (2011) The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye 25, 127-139
32. Shichita, T., Hasegawa, E., Kimura, A., Morita, R., Sakaguchi, R., Takada, I., Sekiya, T., Ooboshi, H., Kitazono, T., Yanagawa, T., Ishii, T., Takahashi, H., Mori, S., Nishibori, M., Kuroda, K., Akira, S., Miyake, K., and Yoshimura, A. (2012) Peroxiredoxin family proteins are key initiators of postischemic inflammation in the brain. Nat. Med. 18, 911-917
33. Luhmann, U. F., Robbie, S., Munro, P. M., Barker, S. E., Duran, Y., Luong, V., Fitzke, F. W., Bainbridge, J. W., Ali, R. R., and MacLaren, R. E. (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest. Ophthalmol. Vis. Sci. 50, 5934-5943
34. Marneros, A. G., She, H., Zambarakji, H., Hashizume, H., Connolly, E. J., Kim, I., Gragoudas, E. S., Miller, J. W., and Olsen, B. R. (2007) Endogenous endostatin inhibits choroidal neovascularization. FASEB J. 21, 3809-3818
35. Huber, M., and Wachtlin, J. (2012) Vitreous levels of proteins implicated in angiogenesis are modulated in patients with retinal or choroidal neovascularization. Ophthalmologica 228, 188-193
36. Mirochnik, Y., Aurora, A., Schulze-Hoepfner, F. T., Deabes, A., Shifrin, V., Beckmann, R., Polsky, C., and Volpert, O. V. (2009) Short pigment epithelial-derived factor-derived peptide inhibits angiogenesis and tumor growth. Clin. Cancer Res. 15, 1655-1663
37. Johnson, M. D., Kim, H. R., Chesler, L., Tsao-Wu, G., Bouck, N., and Polverini, P. J. (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194-202
38. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174
39. Zhuang, X., Xiang, X., Grizzle, W., Sun, D., Zhang, S., Axtell, R. C., Ju, S., Mu, J., Zhang, L., Steinman, L., Miller, D., and Zhang, H. G. (2011) Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779
40. Delcayre, A., and Le Pecq, J. B. (2006) Exosomes as novel therapeutic nanodevices. Curr. Opin. Mol. Ther. 8, 31-38
41. Hao, S., Moyana, T., and Xiang, J. (2007) Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother. Radiopharm. 22, 692-703
42. Lebreton, A., and Séraphin, B. (2008) Exosome-mediated quality control: substrate recruitment and molecular activity. Biochim. Biophys. Acta 1779, 558-565
43. Lorentzen, E., and Conti, E. (2006) The exosome and the proteasome: nano-compartments for degradation. Cell 125, 651-654
44. Courrier, H. M., Butz, N., and Vandamme, T. F. (2002) Pulmonary drug delivery systems: recent developments and prospects. Crit. Rev. Ther. Drug Carrier Syst. 19, 425-498